United States Capecitabine Fumarate Market Report 2017

May 2017 | 96 pages | ID: U0F385E7CD7EN
QYResearch

Abstracts

In this report, the United States Capecitabine Fumarate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Capecitabine Fumarate in these regions, from 2012 to 2022 (forecast).

United States Capecitabine Fumarate market competition by top manufacturers/players, with Capecitabine Fumarate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Sun Pharma Global
• Pfizer
• Dr Reddys
• Mylan
• Sagent Pharms
• Akorn
• Emcure Pharms
• Hikma Farmaceutica
• Gland Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Capecitabine Fumarate Oral
• Capecitabine Fumarate Infusion

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Capecitabine Fumarate for each application, including

• Breast Cancer
• Rectal Cancer
• Colon Cancer
• Gastric Cancer
• Other Malignancies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Capecitabine Fumarate Market Report 2017

1 CAPECITABINE FUMARATE OVERVIEW

1.1 Product Overview and Scope of Capecitabine Fumarate
1.2 Classification of Capecitabine Fumarate by Product Category
  1.2.1 United States Capecitabine Fumarate Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Capecitabine Fumarate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Capecitabine Fumarate Oral
  1.2.4 Capecitabine Fumarate Infusion
1.3 United States Capecitabine Fumarate Market by Application/End Users
  1.3.1 United States Capecitabine Fumarate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Breast Cancer
  1.3.3 Rectal Cancer
  1.3.4 Colon Cancer
  1.3.5 Gastric Cancer
  1.3.6 Other Malignancies
1.4 United States Capecitabine Fumarate Market by Region
  1.4.1 United States Capecitabine Fumarate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Capecitabine Fumarate Status and Prospect (2012-2022)
  1.4.3 Southwest Capecitabine Fumarate Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Capecitabine Fumarate Status and Prospect (2012-2022)
  1.4.5 New England Capecitabine Fumarate Status and Prospect (2012-2022)
  1.4.6 The South Capecitabine Fumarate Status and Prospect (2012-2022)
  1.4.7 The Midwest Capecitabine Fumarate Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Capecitabine Fumarate (2012-2022)
  1.5.1 United States Capecitabine Fumarate Sales and Growth Rate (2012-2022)
  1.5.2 United States Capecitabine Fumarate Revenue and Growth Rate (2012-2022)

2 UNITED STATES CAPECITABINE FUMARATE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Capecitabine Fumarate Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Capecitabine Fumarate Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Capecitabine Fumarate Average Price by Players/Suppliers (2012-2017)
2.4 United States Capecitabine Fumarate Market Competitive Situation and Trends
  2.4.1 United States Capecitabine Fumarate Market Concentration Rate
  2.4.2 United States Capecitabine Fumarate Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Capecitabine Fumarate Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Capecitabine Fumarate Sales and Market Share by Region (2012-2017)
3.2 United States Capecitabine Fumarate Revenue and Market Share by Region (2012-2017)
3.3 United States Capecitabine Fumarate Price by Region (2012-2017)

4 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Capecitabine Fumarate Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Capecitabine Fumarate Revenue and Market Share by Type (2012-2017)
4.3 United States Capecitabine Fumarate Price by Type (2012-2017)
4.4 United States Capecitabine Fumarate Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CAPECITABINE FUMARATE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Capecitabine Fumarate Sales and Market Share by Application (2012-2017)
5.2 United States Capecitabine Fumarate Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CAPECITABINE FUMARATE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Capecitabine Fumarate Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sun Pharma Global
  6.2.2 Capecitabine Fumarate Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sun Pharma Global Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Capecitabine Fumarate Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dr Reddys
  6.4.2 Capecitabine Fumarate Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dr Reddys Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Capecitabine Fumarate Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sagent Pharms
  6.6.2 Capecitabine Fumarate Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sagent Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Akorn
  6.7.2 Capecitabine Fumarate Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Akorn Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Emcure Pharms
  6.8.2 Capecitabine Fumarate Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Emcure Pharms Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Hikma Farmaceutica
  6.9.2 Capecitabine Fumarate Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hikma Farmaceutica Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Gland Pharma
  6.10.2 Capecitabine Fumarate Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Gland Pharma Capecitabine Fumarate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 CAPECITABINE FUMARATE MANUFACTURING COST ANALYSIS

7.1 Capecitabine Fumarate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Capecitabine Fumarate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Capecitabine Fumarate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Capecitabine Fumarate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CAPECITABINE FUMARATE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Capecitabine Fumarate Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Capecitabine Fumarate Sales Volume Forecast by Type (2017-2022)
11.3 United States Capecitabine Fumarate Sales Volume Forecast by Application (2017-2022)
11.4 United States Capecitabine Fumarate Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Capecitabine Fumarate
Figure United States Capecitabine Fumarate Market Size (K MT) by Type (2012-2022)
Figure United States Capecitabine Fumarate Sales Volume Market Share by Type (Product Category) in 2016
Figure Capecitabine Fumarate Oral Product Picture
Figure Capecitabine Fumarate Infusion Product Picture
Figure United States Capecitabine Fumarate Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Capecitabine Fumarate by Application in 2016
Figure Breast Cancer Examples
Figure Rectal Cancer Examples
Figure Colon Cancer Examples
Figure Gastric Cancer Examples
Figure Other Malignancies Examples
Figure United States Capecitabine Fumarate Market Size (Million USD) by Region (2012-2022)
Figure The West Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Capecitabine Fumarate Sales (K MT) and Growth Rate (2012-2022)
Figure United States Capecitabine Fumarate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Capecitabine Fumarate Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Capecitabine Fumarate Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Capecitabine Fumarate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Capecitabine Fumarate Sales Share by Players/Suppliers
Figure 2017 United States Capecitabine Fumarate Sales Share by Players/Suppliers
Figure United States Capecitabine Fumarate Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Capecitabine Fumarate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Capecitabine Fumarate Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Capecitabine Fumarate Revenue Share by Players/Suppliers
Figure 2017 United States Capecitabine Fumarate Revenue Share by Players/Suppliers
Table United States Market Capecitabine Fumarate Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Capecitabine Fumarate Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Capecitabine Fumarate Market Share of Top 3 Players/Suppliers
Figure United States Capecitabine Fumarate Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Capecitabine Fumarate Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Capecitabine Fumarate Product Category
Table United States Capecitabine Fumarate Sales (K MT) by Region (2012-2017)
Table United States Capecitabine Fumarate Sales Share by Region (2012-2017)
Figure United States Capecitabine Fumarate Sales Share by Region (2012-2017)
Figure United States Capecitabine Fumarate Sales Market Share by Region in 2016
Table United States Capecitabine Fumarate Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Capecitabine Fumarate Revenue Share by Region (2012-2017)
Figure United States Capecitabine Fumarate Revenue Market Share by Region (2012-2017)
Figure United States Capecitabine Fumarate Revenue Market Share by Region in 2016
Table United States Capecitabine Fumarate Price (USD/MT) by Region (2012-2017)
Table United States Capecitabine Fumarate Sales (K MT) by Type (2012-2017)
Table United States Capecitabine Fumarate Sales Share by Type (2012-2017)
Figure United States Capecitabine Fumarate Sales Share by Type (2012-2017)
Figure United States Capecitabine Fumarate Sales Market Share by Type in 2016
Table United States Capecitabine Fumarate Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Capecitabine Fumarate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Capecitabine Fumarate by Type (2012-2017)
Figure Revenue Market Share of Capecitabine Fumarate by Type in 2016
Table United States Capecitabine Fumarate Price (USD/MT) by Types (2012-2017)
Figure United States Capecitabine Fumarate Sales Growth Rate by Type (2012-2017)
Table United States Capecitabine Fumarate Sales (K MT) by Application (2012-2017)
Table United States Capecitabine Fumarate Sales Market Share by Application (2012-2017)
Figure United States Capecitabine Fumarate Sales Market Share by Application (2012-2017)
Figure United States Capecitabine Fumarate Sales Market Share by Application in 2016
Table United States Capecitabine Fumarate Sales Growth Rate by Application (2012-2017)
Figure United States Capecitabine Fumarate Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Novartis Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Novartis Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Sun Pharma Global Basic Information List
Table Sun Pharma Global Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharma Global Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Sun Pharma Global Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Sun Pharma Global Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Pfizer Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Pfizer Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Dr Reddys Basic Information List
Table Dr Reddys Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dr Reddys Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Dr Reddys Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Dr Reddys Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Mylan Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Mylan Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Sagent Pharms Basic Information List
Table Sagent Pharms Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sagent Pharms Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Sagent Pharms Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Sagent Pharms Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Akorn Basic Information List
Table Akorn Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Akorn Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Akorn Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Akorn Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Emcure Pharms Basic Information List
Table Emcure Pharms Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Emcure Pharms Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Emcure Pharms Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Emcure Pharms Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Hikma Farmaceutica Basic Information List
Table Hikma Farmaceutica Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hikma Farmaceutica Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Hikma Farmaceutica Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Hikma Farmaceutica Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Gland Pharma Basic Information List
Table Gland Pharma Capecitabine Fumarate Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gland Pharma Capecitabine Fumarate Sales Growth Rate (2012-2017)
Figure Gland Pharma Capecitabine Fumarate Sales Market Share in United States (2012-2017)
Figure Gland Pharma Capecitabine Fumarate Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Capecitabine Fumarate
Figure Manufacturing Process Analysis of Capecitabine Fumarate
Figure Capecitabine Fumarate Industrial Chain Analysis
Table Raw Materials Sources of Capecitabine Fumarate Major Players/Suppliers in 2016
Table Major Buyers of Capecitabine Fumarate
Table Distributors/Traders List
Figure United States Capecitabine Fumarate Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Capecitabine Fumarate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Capecitabine Fumarate Price (USD/MT) Trend Forecast (2017-2022)
Table United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Type in 2022
Table United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Application in 2022
Table United States Capecitabine Fumarate Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Capecitabine Fumarate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Capecitabine Fumarate Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources